SCHEMBL18563183

SCHEMBL18563183

COC(=O)CCNC(=O)CC[C@@H](C)[C@H]1CCC2[C@H]3C(CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@@H]3O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 10/20 0.84
▸ NR1H4 Q96RI1 7/20 0.77
▸ SLC10A2 Q12908 4/20 0.77
▸ ABCB11 O95342 4/20 0.77
▸ ENPP2 Q13822 3/20 0.77
▸ ABCC4 O15439 1/20 0.77
▸ PLA2G1B P04054 1/20 0.77
▸ NR3C1 P04150 1/20 0.73
▸ SLC10A1 Q14973 3/20 0.71
▸ MEN1 O00255 3/20 0.70
▸ KMT2A Q03164 3/20 0.70
▸ CYP3A4 P08684 2/20 0.70
▸ LMNA P02545 1/20 0.70
▸ CYP2C19 P33261 1/20 0.70
▸ CHRM2 P08172 1/20 0.70
▸ ADRA2A P08913 1/20 0.70
▸ ADRA1A P35348 1/20 0.70
▸ TDP1 Q9NUW8 1/20 0.70
▸ CISD1 Q9NZ45 1/20 0.70
▸ SLCO1B3 Q9NPD5 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13297375 1.00 GPBAR1 (0.84) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL12137402 1.00 GPBAR1 (0.84) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL22627117 1.00 GPBAR1 (0.84) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL23345508 0.95 GPBAR1 (0.82) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL22626961 0.95 GPBAR1 (0.82) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL22627109 0.93 GPBAR1 (0.80) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL23345531 0.93 GPBAR1 (0.80) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL13851605 0.92 GPBAR1 (0.78) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL12137424 0.92 GPBAR1 (0.71) GPBAR1NR1H4SLC10A2ABCB11ENPP2
SCHEMBL26714790 0.92 GPBAR1 (0.83) GPBAR1NR1H4SLC10A2ABCB11ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170056419-A1 Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth TUFTS UNIVERSITY 2017-03-02 — — US disclosed
US-20170056419-A1 Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth TUFTS UNIVERSITY 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170056419-A1 Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth SLC10A2, CDC37, NR1H4 GPBAR1 17/4885NR1H4 3/4885SLC10A2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback